In their article, “Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes,” a team led by Eva Feldman, MD, PhD, identify blood fat profiles that can predict diabetes complications, like neuropathy, a decade later.
Pranger ALS Clinic Director Stephen Goutman, MD, was featured on the ALS Association's podcast, Connecting ALS . Listen as he shares new information about ALS risk factors and the burgeoning science of preventing ALS.
This year's theme "Brain Health for All" is already an important initiative for the NeuroNetwork for Emerging Therapies. Watch our core researchers share some of this research, along with some important messages about the World Federation of Neurology's World Brain Day.
Michigan Medicine recently announced the appointment of Aditya S. Pandey, MD, as chair of the Department of Neurosurgery, becoming only the sixth chair of the department’s 100-year history. He replaces Dr. Karin Muraszko, a pediatric neurosurgeon and the first female chair.
Dementia is a growing problem as the world's population ages. Meet Andi and Larry Wolfe, and learn about their plan to fight this horrible condition by funding research through the Andi and Larry Wolfe Wellness Initiative for Brain Health and the Andi and the Larry Wolfe Research Professorship.
The Edith Briskin Emerging Scholar shares the research the award will fund—inflammation as a potential link between cognitive decline and metabolic dysfunction—and her experiences under the mentorship of Dr. Eva Feldman.
The international organization came stateside for its annual meeting this year. Several of our team members took center stage as chairs or featured speakers and two of our rising stars shared their latest groundbreaking research at the platform and poster presentations.
A robust partnership among the NeuroNetwork for Emerging Therapies, the ALS Center of Excellence, and the University of Michigan School of Public Health has produced an important publication in the International Archives of Occupational and Environmental Health, entitled “Associations of self‑reported occupational exposures and settings to ALS
In a preview of the session "Emerging Directions in Diabetic Neuropathy" at the American Diabetes Association 82nd Scientific Sessions, the ADA interviewed Dr. Eid about her upcoming talk, "Mitochondria as New Therapeutic Targets in Diabetic Neuropathy."